Expanding New Applications for Chemical Products and Reducing Refining Costs

「Meanwhile, in the Mold Manufacturing segment, the automotive industry as a whole remained uncertain and automotive applications had not yet recovered. In office-equipment applications, sales remained sluggish because the business was between development projects, but the Company is actively expanding into new fields, primarily medical applications.」

「Sales in office equipment applications have been sluggish because the business is between development projects, but we are actively expanding into new fields, particularly the medical sector.」

「In the Mold Manufacturing segment, conditions in automotive applications remained uncertain because of quality scandals at automotive manufacturers, delays in the shift toward EVs, and the impact of tariffs on exports to the United States, but inquiries for projects toward fiscal 2026 have increased and signs of recovery are emerging. In office-equipment applications, however, conditions remained difficult because the business was between development projects and demand for hot runners for in-vehicle connectors and smartphones was sluggish.」

「In the Specialty Chemicals segment, orders for components for medical equipment and digital cameras remained solid, resulting in higher revenue year on year. In the Mold Manufacturing segment, conditions remained uncertain because of quality scandals at automotive manufacturers, moves toward management integration among major companies, and delays in the shift toward EVs.」

「The Specialty Chemicals segment worked to deepen sales to medical customers and existing customers, but revenue increased and profit declined year on year because of the depreciation expense burden from capital investment.」

「In the molded-products division of the Specialty Chemicals business, orders for components for medical equipment remained solid and increased revenue, while molded products for digital cameras saw revenue decline because of the semiconductor shortage. The Mold Manufacturing segment struggled as new orders for automotive molds declined because of the semiconductor shortage and the transitional shift toward EVs, but revenue increased after a company with strengths in molds for office and medical equipment was added to the Group.」

「In the Trading segment, the Company worked to improve profitability by focusing on more profitable, more secure transactions and making effective use of sales through agents.」

「In the Specialty Chemicals segment, performance remained solid, driven by orders for components for medical equipment, as the medical plastics market recovered. In the Mold Manufacturing segment, the mold-manufacturing subsidiary acquired and consolidated from 1 November 2022 contributed to an increase in revenue year on year.」

「In the Specialty Chemicals segment, orders for components for digital cameras and medical equipment remained solid as signs of a bottom emerged in the shrinking digital-camera market and the medical plastics market recovered. In the Mold Manufacturing segment, the automotive market began to recover and orders for new molds remained strong. Revenue also increased at the mold-manufacturing subsidiary acquired and consolidated from 1 November 2022.」

「In the Specialty Chemicals segment, orders for components for digital cameras and medical equipment remained solid as signs of a bottom emerged in the shrinking digital-camera market and the medical plastics market recovered. In the Mold Manufacturing segment, the automotive market began to recover. Revenue also increased at the mold-manufacturing subsidiary acquired and consolidated from 1 November 2022, although acquisition-related expenses were incurred for its shares.」

「In the Specialty Chemicals segment, demand for components for digital cameras and medical equipment recovered as supply shortages of parts and materials gradually eased. In the Mold Manufacturing segment, demand remained solid and recovered while the automotive industry continued to reduce production because of the semiconductor shortage. Acquisition-related expenses were incurred for the shares of a subsidiary acquired on 1 November. In the Trading segment, profitability improved by focusing on highly profitable, highly secure transactions. As a result, revenue increased by ¥151 million, or 12.7%, year on year to ¥1,338 million, while operating profit increased by ¥37 million, or 146.7%, to ¥63 million.」

「In the Specialty Chemicals segment, demand for components for digital cameras and medical equipment recovered from the declines seen since the COVID-19 pandemic. In the Mold Manufacturing segment, demand overall remained solid and recovered, although the automotive industry continued to reduce production because of the semiconductor shortage. In the Trading segment, profitability improved by focusing on transactions with higher profitability and safety. As a result, revenue increased by ¥40 million, or 7.2%, year on year to ¥606 million, while operating profit increased by ¥61 million, or 1,574.8%, to ¥64 million.」

「In the Specialty Chemicals segment, demand for digital-camera components declined as smartphones became more widespread, but personal consumption, which had gradually weakened during the COVID-19 pandemic, began to recover, and performance remained solid. Components for medical equipment also began to recover. In the Mold Manufacturing segment, mass-production molds for model changes by automotive and motorcycle manufacturers struggled as the automotive industry was forced to adjust production because of the prolonged shortage of semiconductor components and rising raw-material prices.」

「In the Specialty Chemicals segment, components for digital cameras were affected by COVID-19 but had moved past their temporary trough and were beginning to recover, while components for medical equipment remained solid. In the Mold Manufacturing segment, mass-production molds for model changes by automotive and motorcycle manufacturers struggled as the automotive industry was forced to adjust production because of the semiconductor shortage.」

「In the Specialty Chemicals business, orders for digital-camera components declined from some customers affected by COVID-19, while components for medical equipment remained solid. In the Mold Manufacturing segment, mass-production molds for model changes by automotive and motorcycle manufacturers remained solid.」

「In the Specialty Chemicals business, components for digital cameras declined, but components for medical equipment remained solid, and operations began on a new production line at the Oita Plant.」

「In the chemical compounds business, components for digital cameras struggled, but components for medical equipment remained firm, while the plastic injection-molding die subsidiary included in the consolidated group on 1 October 2018 contributed to increases in sales and profit year on year.」

「The Specialty Chemicals business saw solid performance in components for digital cameras and medical equipment, while profitability also improved for automotive components.」

「In the Specialty Chemicals segment, components for digital cameras and medical equipment remained solid, while profitability also improved for automotive components.」

「In the Specialty Chemicals segment, components for digital cameras and medical equipment remained solid, while profitability also improved for automotive components.」

「In the Specialty Chemicals segment, components for medical equipment, which the Company is developing as a new application, expanded, while components for digital cameras also began to recover. The Refining segment worked to reduce solvent recovery costs, primarily through lower energy costs.」

「In the Specialty Chemicals segment, components for medical equipment, which the Company is developing as a new application, expanded, while components for digital cameras also began to recover. The Refining segment worked to reduce solvent recovery costs, primarily through lower energy costs.」